Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 524045, 7 pages
http://dx.doi.org/10.1155/2014/524045
Clinical Study

Long Term Survival Analysis of Hepatectomy for Neuroendocrine Tumour Liver Metastases

Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong

Received 26 August 2013; Accepted 24 October 2013; Published 12 January 2014

Academic Editors: A. Cooperman, J. S. Gold, and S.-N. Lu

Copyright © 2014 Tan To Cheung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Frilling, G. C. Sotiropoulos, J. Li, O. Kornasiewicz, and U. Plöckinger, “Multimodal management of neuroendocrine liver metastases,” HPB, vol. 12, no. 6, pp. 361–379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. C. Mayo, M. C. de Jong, M. Bloomston et al., “Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis,” Annals of Surgical Oncology, vol. 18, no. 13, pp. 3657–3665, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. B. Bomanji and N. D. Papathanasiou, “111In-DTPA0-octreotide (Octreoscan), 131I-MIBG and other agents for radionuclide therapy of NETs,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 1, supplement 1, pp. S113–S125, 2012. View at Publisher · View at Google Scholar
  4. C. Nanni, D. Rubello, and S. Fanti, “18F-DOPA PET/CT and neuroendocrine tumours,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 5, pp. 509–513, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. Koornstra, E. G. E. de Vries, and R. J. Porte, “Improvements in small bowel carcinoid diagnosis and staging: 18F-DOPA PET, capsule endoscopy and double balloon enteroscopy,” Digestive and Liver Disease, vol. 41, no. 7, pp. e35–e38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. K. K. Wong, R. T. Waterfield, M. C. Marzola et al., “Contemporary nuclear medicine imaging of neuroendocrine tumours,” Clinical Radiology, vol. 67, no. 11, pp. 1035–1050, 2012. View at Publisher · View at Google Scholar
  7. A. S. Ho, J. Picus, M. D. Darcy et al., “Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors,” The American Journal of Roentgenology, vol. 188, no. 5, pp. 1201–1207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Rosenau, M. J. Bahr, R. von Wasielewski et al., “Ki67, e-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors,” Transplantation, vol. 73, no. 3, pp. 386–394, 2002. View at Google Scholar · View at Scopus
  9. E. Liapi, C. C. Georgiades, K. Hong, and J. H. Geschwind, “Transcatheter arterial chemoembolization: current technique and future promise,” Techniques in Vascular and Interventional Radiology, vol. 10, no. 1, pp. 2–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Roche, B. V. Girish, T. de Baère et al., “Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors,” European Radiology, vol. 13, no. 1, pp. 136–140, 2003. View at Google Scholar · View at Scopus
  11. J. G. Touzios, J. M. Kiely, S. C. Pitt et al., “Neuroendocrine hepatic metastases: does aggressive management improve survival?” Annals of Surgery, vol. 241, no. 5, pp. 776–785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. R. S. Chamberlain, D. Canes, K. T. Brown et al., “Hepatic neuroendocrine metastases: does intervention alter outcomes?” Journal of the American College of Surgeons, vol. 190, no. 4, pp. 432–445, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Sarmiento, G. Heywood, J. Rubin, D. M. Ilstrup, D. M. Nagorney, and F. G. Que, “Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival,” Journal of the American College of Surgeons, vol. 197, no. 1, pp. 29–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. D. C. Madoff, S. Gupta, K. Ahrar, R. Murthy, and J. C. Yao, “Update on the management of neuroendocrine hepatic metastases,” Journal of Vascular and Interventional Radiology, vol. 17, no. 8, pp. 1235–1249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. S. T. Fan, C. M. Lo, C. L. Liu et al., “Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths,” Annals of Surgery, vol. 229, no. 3, pp. 322–330, 1999. View at Google Scholar · View at Scopus
  16. R. B. Adams and B. Langer, “Resection margins for colorectal metastases to the liver: do they make a difference?” HPB Surgery, vol. 9, no. 2, pp. 115–117, 1996. View at Google Scholar · View at Scopus
  17. T. T. Cheung, K. S. Chok, A. C. Chan et al., “Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour,” ANZ Journal of Surgery, 2013. View at Publisher · View at Google Scholar
  18. E. S. Glazer, J. F. Tseng, W. Al-Refaie et al., “Long-term survival after surgical management of neuroendocrine hepatic metastases,” HPB, vol. 12, no. 6, pp. 427–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. R. T. Poon, S. T. Fan, C. M. Lo et al., “Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?” Annals of Surgery, vol. 236, no. 5, pp. 602–611, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. T. T. Cheung, S. C. Chan, K. S. Chok et al., “Rapid measurement of indocyanine green retention by pulse spectrophotometry: a validation study in 70 patients with Child-Pugh A cirrhosis before hepatectomy for hepatocellular carcinoma,” Hepatobiliary and Pancreatic Diseases International, vol. 11, no. 3, pp. 267–271, 2012. View at Publisher · View at Google Scholar
  21. S. T. Fan, C. Mau Lo, R. T. Poon et al., “Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience,” Annals of Surgery, vol. 253, no. 4, pp. 745–758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Yau, T. J. Yao, P. Chan et al., “The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization,” Cancer, vol. 115, no. 23, pp. 5507–5515, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. S. Cho, D. M. Labow, L. Tang et al., “Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms,” Cancer, vol. 113, no. 1, pp. 126–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. C. Mayo, M. C. de Jong, C. Pulitano et al., “Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis,” Annals of Surgical Oncology, vol. 17, no. 12, pp. 3129–3136, 2010. View at Publisher · View at Google Scholar · View at Scopus